Abstract：
English-language reporting on the continuing difficulties in accessing Evusheld reflects the marginalization of immunocompromised people in discussions about the public policy response to Covid-19. Moreover, the lack of available data on global Evusheld access, particularly in low-income countries, has emerged as a key form of nonknowledge that must be redressed within public health research. Through examining how knowledge about domestic and global barriers to Evusheld access circulates, and does not circulate, within The New York Times, this paper identifies a case study of the social production of ignorance related to a key issue in the Covid-19 pandemic. Drawing on science and technology studies, the history of science and media studies, I situate these trends in the context of longer explanatory histories of nonknowledge. First, through a critical discourse analysis of the New York Times\' reporting on Evusheld access in the U.S., I trace the individualizing framework evident in many articles to longstanding trends in reporting on health and illness, and to the structural marginalization of immunocompromised people in U.S. Secondly, I argue that the near-total absence of reporting on Evusheld access in low-income countries is consistent with the longstanding structural neglect of health crises in the global south.
摘要：
关于访问Evusheld的持续困难的英文报告反映了免疫功能低下的人在讨论对新冠肺炎的公共政策反应时被边缘化。此外，缺乏有关全球Evusheld访问的可用数据，特别是在低收入国家，已成为公共卫生研究中必须纠正的非知识的关键形式。通过研究有关Evusheld访问的国内和全球障碍的知识如何传播，并且不流通，在《纽约时报》中，本文确定了与Covid-19大流行中的一个关键问题有关的社会生产无知的案例研究。借鉴科学技术研究，科学和媒体研究的历史，我将这些趋势置于非知识的更长解释性历史的背景下。首先,通过对《纽约时报》关于美国Evusheld访问权的报道的批判性话语分析，我将许多文章中明显的个性化框架追溯到健康和疾病报告的长期趋势，以及美国免疫受损人群的结构性边缘化。我认为，在低收入国家，几乎完全没有关于Evusheld获取服务的报告，这与长期以来对全球南部健康危机的结构性忽视是一致的。
